언어 선택

Anti-CD3 Antibody

제품 문의

임상 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	적응증	임상 시험
Plerixafor/Tacrolimus Hydrate	MRG-001(MedRegen); AMD3100+FK506	Phase 2 Clinical	MedRegen LLC	Hepatitis, Alcoholic; Motor Neuron Disease; Cytokine Release Syndrome; Respiratory Tract Diseases; Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Abdominal Injuries; Wounds and Injuries; Amyotrophic Lateral Sclerosis; Respiratory Insufficiency	상세
Rimiducid	AP-1903	Phase 2 Clinical	Ariad Pharmaceuticals Inc, Bellicum Pharmaceuticals Inc	Neuroblastoma; Multiple Myeloma; Prostatic Neoplasms, Castration-Resistant; Uveal melanoma; Anemia, Aplastic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Metabolic Diseases; Prostatic Neoplasms; Osteopetrosis; Osteosarcoma; Sarcoma; Blastic Plasmacytoid Dendritic Cell Neoplasm; Colorectal Neoplasms; Lymphoma, Non-Hodgkin; Lymphoma; Leukemia, Myeloid, Acute; Lymphohistiocytosis, Hemophagocytic; Anemia, Sickle Cell; Leukemia, Biphenotypic, Acute; Leukemia, Lymphocytic, Chronic, B-Cell; Congenital Bone Marrow Failure Syndromes; Melanoma; Thalassemia; Leukemia, Myelogenous, Chronic; Bone Marrow Neoplasms; Leukemia; Hematologic Neoplasms; Lymphoma, B-Cell; Neoplasm, Residual; Solid tumours; Immunoproliferative Disorders; Leukemia, Lymphoid; Lymphatic Diseases; Primary Immunodeficiency Diseases; Anemia, Diamond-Blackfan; Graft vs Host Disease; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Myeloproliferative Disorders; Hemoglobinopathies; Fanconi Anemia; Neoplasms; Immune System Diseases	상세

시판 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	가장 빠른 브랜드 이름	가장 빠른 승인 국가	가장 빠른 적응증	가장 빠른 승인 회사	가장 빠른 승인 날짜	적응증	임상 시험
Tacrolimus Hydrate	LCP-Tacro; FR-900506; L-679934; FK-506MR; FK-506E; FK-506; MR-4; RTU-007	Approved	Astellas Pharma Inc	Protopy, Graceptor (as hydrate), Protopic, Prograf (as hydrate), Hecoria (as hydrate), Hexal, Envarsus XR, Talymus, 普乐可复, Advagraf, Envarsus, Modigraf, Astagraf XL, TacroBell	United States	Rejection in heart transplantation; Rejection of renal transplantation; Rejection of liver transplantation	Astellas Pharma Us Inc	1994-04-08	Keratoconjunctivitis; Dry Eye Syndromes; Conjunctivitis; Psoriasis; Pulmonary Arterial Hypertension; Amputation, Traumatic; Burns; Asthma; Surgical Wound Infection; Colitis, Ulcerative; Rejection in heart transplantation; Infertility, Female; Lupus Nephritis; Hamman-Rich Syndrome; Nephrotic Syndrome; Renal Insufficiency, Chronic; Wounds and Injuries; Vitiligo; Dermatitis, Atopic; Peripheral Nerve Injuries; Ocular inflammation; Edema; Encephalitis; Crohn Disease; Glomerulonephritis, IGA; Rejection of renal transplantation; Reperfusion Injury; Myasthenia Gravis; Medication Adherence; Keratoconjunctivitis Sicca; Genital Diseases, Male; Bone marrow transplant rejection; Liver Failure; Rejection of lung transplantation; Rejection of liver transplantation; Renal Insufficiency; Polymyositis; Primary Graft Dysfunction; Rejection of pancreatic transplantation; Keratoplasty rejection; Dermatomyositis; Kidney Diseases; Lupus Erythematosus, Cutaneous; Graft vs Host Disease; Arthritis, Rheumatoid; Lung Diseases, Intersti	상세

제품 문의
시판 약물 정보
임상 약물 정보

웹사이트 피드백

문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

이메일
order.kr@acrobiosystems.com

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호